We are united to confront future epidemics

Our goal is to explore how viruses and bacteria affect organisms, and to use the knowledge gained for the development of antibacterial and antiviral drugs.

We are top research institutes from all over Czechia

NIVB is a unique research platform that brings together top research institutes from all over the Czech Republic working with the aim of accelerating the development of drugs and vaccines against viral and bacterial diseases.

• Masaryk University
• Charles University
• University of Chemistry and Technology, Prague
• Palacký University Olomouc
• Institute of Organic Chemistry and Biochemistry of the CAS
• Institute of Molecular Genetics of the CAS
• Institute of Microbiology of the CAS
• Biology Centre of the CAS

We are funded by the EXCELES project, which supports excellent research in the field of healthcare

The National Institute of Virology and Bacteriology (ID Project No. LX22NPO5103) is supported by the Program for Public Research & Development Support for Priority Areas of Medical Sciences and Related Social Sciences – EXCELES, which is funded by the European Union’s Recovery and Resilience Facility, the centrepiece of the NextGenerationEU scheme.

The National Institute of Virology and Bacteriology focuses on basic and applied research of pathogens with significant socio-economic impact. The NIVB strives to identify ways of mitigating the negative effects of these infectious diseases on society while strengthening the resistance of the population and, ultimately, the economy. Building economic, health and societal resilience is one of the main objectives of the Recovery and Resilience Facility (RRF), which drives investment in research, development and innovation in EU Member States.